 Judith Gault
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 2 | 2020 | 38 | 1.590 |
Why?
| | Microtubule-Associated Proteins | 3 | 2009 | 214 | 0.960 |
Why?
| | Essential Tremor | 1 | 2020 | 5 | 0.900 |
Why?
| | Schizophrenia | 5 | 2017 | 597 | 0.810 |
Why?
| | Thalamus | 1 | 2020 | 105 | 0.800 |
Why?
| | Corpus Striatum | 1 | 2020 | 171 | 0.780 |
Why?
| | Evoked Potentials, Auditory | 2 | 2020 | 267 | 0.780 |
Why?
| | Hemangioma, Cavernous, Central Nervous System | 4 | 2006 | 8 | 0.780 |
Why?
| | Proto-Oncogene Proteins | 3 | 2009 | 693 | 0.770 |
Why?
| | Psychotic Disorders | 1 | 2020 | 268 | 0.630 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 26 | 0.490 |
Why?
| | Receptors, Nicotinic | 4 | 2009 | 338 | 0.410 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 200 | 0.390 |
Why?
| | Point Mutation | 1 | 2009 | 259 | 0.380 |
Why?
| | Cerebrovascular Disorders | 2 | 2006 | 82 | 0.370 |
Why?
| | Polymorphism, Single-Stranded Conformational | 2 | 2003 | 39 | 0.310 |
Why?
| | Germ-Line Mutation | 1 | 2005 | 113 | 0.300 |
Why?
| | Endothelial Cells | 1 | 2009 | 578 | 0.290 |
Why?
| | Gene Duplication | 1 | 2003 | 78 | 0.280 |
Why?
| | KRIT1 Protein | 3 | 2009 | 5 | 0.280 |
Why?
| | Genetic Linkage | 1 | 2003 | 380 | 0.260 |
Why?
| | Membrane Proteins | 1 | 2009 | 1049 | 0.260 |
Why?
| | Chromosomes, Human, Pair 15 | 4 | 2009 | 91 | 0.250 |
Why?
| | Hemorrhage | 1 | 2005 | 526 | 0.230 |
Why?
| | DNA Mutational Analysis | 4 | 2009 | 418 | 0.210 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2006 | 1979 | 0.200 |
Why?
| | Neural Pathways | 1 | 2020 | 337 | 0.180 |
Why?
| | Risk Assessment | 1 | 2006 | 2934 | 0.180 |
Why?
| | Brain | 3 | 2006 | 2662 | 0.160 |
Why?
| | Genotype | 4 | 2009 | 2038 | 0.150 |
Why?
| | Exons | 2 | 2005 | 318 | 0.140 |
Why?
| | Sequence Analysis, DNA | 3 | 2005 | 790 | 0.130 |
Why?
| | Base Sequence | 3 | 2009 | 2364 | 0.120 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 4 | 2009 | 128 | 0.120 |
Why?
| | Humans | 14 | 2020 | 104249 | 0.110 |
Why?
| | Sequence Deletion | 1 | 2009 | 197 | 0.100 |
Why?
| | Middle Aged | 4 | 2020 | 27633 | 0.100 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 3197 | 0.100 |
Why?
| | Promoter Regions, Genetic | 2 | 2003 | 1260 | 0.090 |
Why?
| | Gene Frequency | 1 | 2009 | 552 | 0.090 |
Why?
| | Gene Expression | 2 | 2004 | 1525 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 3 | 2009 | 2842 | 0.090 |
Why?
| | Genetic Variation | 2 | 2003 | 945 | 0.090 |
Why?
| | Dementia, Vascular | 1 | 2006 | 14 | 0.090 |
Why?
| | Central Nervous System Cysts | 1 | 2006 | 14 | 0.090 |
Why?
| | Cerebral Arteries | 1 | 2006 | 56 | 0.090 |
Why?
| | Brain Neoplasms | 2 | 2004 | 904 | 0.080 |
Why?
| | Alleles | 2 | 2009 | 875 | 0.080 |
Why?
| | Genetic Markers | 2 | 2005 | 422 | 0.080 |
Why?
| | Heterozygote | 1 | 2006 | 275 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1154 | 0.080 |
Why?
| | Spinal Cord Neoplasms | 1 | 2004 | 36 | 0.080 |
Why?
| | Male | 6 | 2020 | 58392 | 0.070 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2004 | 10 | 0.070 |
Why?
| | Female | 6 | 2020 | 59707 | 0.070 |
Why?
| | Genetic Testing | 1 | 2006 | 368 | 0.070 |
Why?
| | Calcinosis | 1 | 2006 | 287 | 0.070 |
Why?
| | Central Nervous System Neoplasms | 1 | 2004 | 115 | 0.070 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 20 | 0.070 |
Why?
| | Gene Deletion | 1 | 2005 | 391 | 0.070 |
Why?
| | Family | 1 | 2006 | 542 | 0.070 |
Why?
| | Introns | 1 | 2003 | 244 | 0.070 |
Why?
| | Aged | 2 | 2020 | 18934 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 378 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2005 | 672 | 0.060 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 286 | 0.060 |
Why?
| | Neural Inhibition | 1 | 2002 | 183 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2291 | 0.060 |
Why?
| | Prevalence | 1 | 2006 | 2225 | 0.060 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 313 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2236 | 0.050 |
Why?
| | RNA | 1 | 2005 | 757 | 0.050 |
Why?
| | Mutation | 2 | 2006 | 3174 | 0.050 |
Why?
| | Stroke | 1 | 2005 | 820 | 0.050 |
Why?
| | Colorado | 1 | 2006 | 4483 | 0.040 |
Why?
| | Child, Preschool | 1 | 2009 | 9106 | 0.040 |
Why?
| | Signal Transduction | 2 | 2004 | 4845 | 0.030 |
Why?
| | Risk Factors | 1 | 2006 | 8467 | 0.030 |
Why?
| | Adolescent | 2 | 2009 | 17541 | 0.030 |
Why?
| | Adult | 4 | 2006 | 30359 | 0.030 |
Why?
| | Polymorphism, Genetic | 2 | 2009 | 781 | 0.030 |
Why?
| | Blotting, Southern | 1 | 2009 | 83 | 0.030 |
Why?
| | Gene Dosage | 1 | 2009 | 158 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 333 | 0.020 |
Why?
| | Headache Disorders | 1 | 2006 | 9 | 0.020 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2006 | 17 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 79 | 0.020 |
Why?
| | Intracranial Hemorrhages | 1 | 2006 | 67 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 312 | 0.020 |
Why?
| | Patient Selection | 1 | 2009 | 693 | 0.020 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2004 | 4 | 0.020 |
Why?
| | Angiopoietins | 1 | 2004 | 8 | 0.020 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2004 | 75 | 0.020 |
Why?
| | Hepatocyte Growth Factor | 1 | 2004 | 32 | 0.020 |
Why?
| | Genetic Counseling | 1 | 2004 | 55 | 0.020 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2004 | 92 | 0.020 |
Why?
| | European Continental Ancestry Group | 1 | 2009 | 1337 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2004 | 107 | 0.020 |
Why?
| | African Americans | 1 | 2009 | 1040 | 0.020 |
Why?
| | Auditory Perceptual Disorders | 1 | 2002 | 13 | 0.020 |
Why?
| | Corpus Callosum | 1 | 2003 | 57 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2006 | 448 | 0.020 |
Why?
| | Temporal Arteries | 1 | 2003 | 49 | 0.020 |
Why?
| | Temporal Lobe | 1 | 2003 | 98 | 0.020 |
Why?
| | Hispanic Americans | 1 | 2009 | 1051 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2004 | 267 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2002 | 144 | 0.020 |
Why?
| | Anticoagulants | 1 | 2006 | 532 | 0.020 |
Why?
| | Frontal Lobe | 1 | 2003 | 170 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2002 | 581 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2004 | 491 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 383 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 465 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 853 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 684 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 519 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2341 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 970 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 2862 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2914 | 0.010 |
Why?
| | Child | 1 | 2003 | 15648 | 0.000 |
Why?
|
|
Gault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|